Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Alcohol Consumption and the Risk of Colorectal Cancer for Mismatch Repair Gene Mutation Carriers.

Dashti SG, Buchanan DD, Jayasekara H, Ait Ouakrim D, Clendenning M, Rosty C, Winship IM, Macrae FA, Giles GG, Parry S, Casey G, Haile RW, Gallinger S, Le Marchand L, Thibodeau SN, Lindor NM, Newcomb PA, Potter JD, Baron JA, Hopper JL, Jenkins MA, Win AK.

Cancer Epidemiol Biomarkers Prev. 2017 Mar;26(3):366-375. doi: 10.1158/1055-9965.EPI-16-0496. Epub 2016 Nov 3.

PMID:
27811119
2.

Risk factors for metachronous colorectal cancer following a primary colorectal cancer: A prospective cohort study.

Jayasekara H, Reece JC, Buchanan DD, Rosty C, Dashti SG, Ait Ouakrim D, Winship IM, Macrae FA, Boussioutas A, Giles GG, Ahnen DJ, Lowery J, Casey G, Haile RW, Gallinger S, Le Marchand L, Newcomb PA, Lindor NM, Hopper JL, Parry S, Jenkins MA, Win AK.

Int J Cancer. 2016 Sep 1;139(5):1081-90. doi: 10.1002/ijc.30153. Epub 2016 May 9.

3.

Multivitamin, calcium and folic acid supplements and the risk of colorectal cancer in Lynch syndrome.

Chau R, Dashti SG, Ait Ouakrim D, Buchanan DD, Clendenning M, Rosty C, Winship IM, Young JP, Giles GG, Macrae FA, Boussioutas A, Parry S, Figueiredo JC, Levine AJ, Ahnen DJ, Casey G, Haile RW, Gallinger S, Le Marchand L, Thibodeau SN, Lindor NM, Newcomb PA, Potter JD, Baron JA, Hopper JL, Jenkins MA, Win AK.

Int J Epidemiol. 2016 Jun;45(3):940-53. doi: 10.1093/ije/dyw036. Epub 2016 Apr 10.

4.

Quantifying the utility of single nucleotide polymorphisms to guide colorectal cancer screening.

Jenkins MA, Makalic E, Dowty JG, Schmidt DF, Dite GS, MacInnis RJ, Ait Ouakrim D, Clendenning M, Flander LB, Stanesby OK, Hopper JL, Win AK, Buchanan DD.

Future Oncol. 2016 Feb;12(4):503-13. doi: 10.2217/fon.15.303. Epub 2016 Feb 1. Review.

5.

Response.

Ait Ouakrim D, Dashti SG, Win AK.

J Natl Cancer Inst. 2015 Dec 27;108(2). pii: djv385. doi: 10.1093/jnci/djv385. Print 2016 Feb. No abstract available.

6.

Determining the familial risk distribution of colorectal cancer: a data mining approach.

Chau R, Jenkins MA, Buchanan DD, Ait Ouakrim D, Giles GG, Casey G, Gallinger S, Haile RW, Le Marchand L, Newcomb PA, Lindor NM, Hopper JL, Win AK.

Fam Cancer. 2016 Apr;15(2):241-51. doi: 10.1007/s10689-015-9860-6.

7.

Trends in colorectal cancer mortality in Europe: retrospective analysis of the WHO mortality database.

Ait Ouakrim D, Pizot C, Boniol M, Malvezzi M, Boniol M, Negri E, Bota M, Jenkins MA, Bleiberg H, Autier P.

BMJ. 2015 Oct 6;351:h4970. doi: 10.1136/bmj.h4970.

8.

Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome.

Ait Ouakrim D, Dashti SG, Chau R, Buchanan DD, Clendenning M, Rosty C, Winship IM, Young JP, Giles GG, Leggett B, Macrae FA, Ahnen DJ, Casey G, Gallinger S, Haile RW, Le Marchand L, Thibodeau SN, Lindor NM, Newcomb PA, Potter JD, Baron JA, Hopper JL, Jenkins MA, Win AK.

J Natl Cancer Inst. 2015 Jun 24;107(9). pii: djv170. doi: 10.1093/jnci/djv170. Print 2015 Sep.

9.

Short-term risk of colorectal cancer in individuals with lynch syndrome: a meta-analysis.

Jenkins MA, Dowty JG, Ait Ouakrim D, Mathews JD, Hopper JL, Drouet Y, Lasset C, Bonadona V, Win AK.

J Clin Oncol. 2015 Feb 1;33(4):326-31. doi: 10.1200/JCO.2014.55.8536. Epub 2014 Dec 22.

PMID:
25534380
10.

Perceived versus predicted risks of colorectal cancer and self-reported colonoscopies by members of mismatch repair gene mutation-carrying families who have declined genetic testing.

Flander L, Speirs-Bridge A, Rutstein A, Niven H, Win AK, Ait Ouakrim D, Hopper JL, Macrae F, Keogh L, Gaff C, Jenkins M.

J Genet Couns. 2014 Feb;23(1):79-88. doi: 10.1007/s10897-013-9614-2. Epub 2013 Jun 9.

11.

Screening participation for people at increased risk of colorectal cancer due to family history: a systematic review and meta-analysis.

Ait Ouakrim D, Lockett T, Boussioutas A, Hopper JL, Jenkins MA.

Fam Cancer. 2013 Sep;12(3):459-72. doi: 10.1007/s10689-013-9658-3. Review.

PMID:
23700069
12.

Screening participation predictors for people at familial risk of colorectal cancer: a systematic review.

Ait Ouakrim D, Lockett T, Boussioutas A, Keogh L, Flander LB, Hopper JL, Jenkins MA.

Am J Prev Med. 2013 May;44(5):496-506. doi: 10.1016/j.amepre.2013.01.022. Review.

PMID:
23597814
13.

Screening practices of Australian men and women categorized as "at or slightly above average risk" of colorectal cancer.

Ait Ouakrim D, Lockett T, Boussioutas A, Keogh L, Flander LB, Winship I, Giles GG, Hopper JL, Jenkins MA.

Cancer Causes Control. 2012 Nov;23(11):1853-64. doi: 10.1007/s10552-012-0067-y. Epub 2012 Sep 26.

14.

Screening practices of unaffected people at familial risk of colorectal cancer.

Ait Ouakrim D, Boussioutas A, Lockett T, Winship I, Giles GG, Flander LB, Keogh L, Hopper JL, Jenkins MA.

Cancer Prev Res (Phila). 2012 Feb;5(2):240-7. doi: 10.1158/1940-6207.CAPR-11-0229. Epub 2011 Oct 26.

15.

The effect of financial incentives on the quality of health care provided by primary care physicians.

Scott A, Sivey P, Ait Ouakrim D, Willenberg L, Naccarella L, Furler J, Young D.

Cochrane Database Syst Rev. 2011 Sep 7;(9):CD008451. doi: 10.1002/14651858.CD008451.pub2. Review.

PMID:
21901722
16.

Determinants of the number of mammography units in 31 countries with significant mammography screening.

Autier P, Ait Ouakrim D.

Br J Cancer. 2008 Oct 7;99(7):1185-90. doi: 10.1038/sj.bjc.6604657. Epub 2008 Sep 9. Erratum in: Br J Cancer. 2008 Dec 2;99(11):1958. Ouakrim, D A [corrected to Ait Ouakrim, D].

Supplemental Content

Loading ...
Support Center